PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Chair of Experimental Bioinformatics, Technical University of Munich, Freising, Germany.\', \'Natural Sciences Department, Universidad Autónoma Metropolitana-Cuajimalpa, Mexico City, Mexico.\', \'Department of Internal Medicine I, School of Medicine, University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.\', \'German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.\', \'Department of Cardiovascular Medicine, Humanitas Clinical and Research Center IRCCS, Humanitas University, Rozzano, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1089/adt.2020.1010
?:hasPublicationType
?:journal
  • Assay and drug development technologies
is ?:pmid of
?:pmid
?:pmid
  • 33164550
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.033
?:rankingScore_hIndex
  • 50
?:title
  • Individuating Possibly Repurposable Drugs and Drug Targets for COVID-19 Treatment Through Hypothesis-Driven Systems Medicine Using CoVex.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33164550>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33164550>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all